Bayer to promote men’s well being product or service Nebido™ to Grünenthal

Bayer to promote men’s well being product or service Nebido™ to Grünenthal


Berlin, July 14, 2022 – Bayer and Grünenthal have entered into a definitive settlement about the sale of Bayer’s men’s health and fitness product Nebido™ (testosterone undecanoate), for a obtain selling price totaling up to five hundred million Euro.

Nebido for the procedure of male hypogonadism (testosterone deficiency) is obtainable in around 80 countries because 2004. In 2021, the product contributed profits of 117 million Euro to Bayer’s total income of extra than 44 billion Euro.

“This divestment is component of the ongoing transformation of our pharmaceuticals small business, which focuses on critical parts of healthcare innovation,” explained Marianne De Backer, PhD, MBA, Member of the Govt Committee and EVP, Head Strategy and Enterprise Growth & Licensing and Open Innovation, Prescribed drugs Division of Bayer AG. “Its proceeds will assist investments in potential innovation and carry ahead transformative treatment solutions for sufferers.”

Grünenthal will get the global product legal rights to Nebido™ for an upfront acquire selling price of up to five hundred million Euro, subject to customary closing adjustments, like the deal small business in the U.S, the place Endo Pharmaceuticals has accredited the compound beneath the identify Aveed from Bayer. The transaction is expected to shut by the finish of 2022, pending the fulfillment of customary closing circumstances, which includes approval by the competitors authorities.

UBS Financial commitment Financial institution acted as monetary advisor to Bayer, when Allen & Overy supplied legal guidance.

About Bayer

Bayer is a international enterprise with core competencies in the lifestyle science fields of wellness care and nutrition. Its products and providers are created to aid folks and the earth thrive by supporting efforts to master the main challenges introduced by a developing and growing older world population. Bayer is fully commited to driving sustainable progress and producing a constructive influence with its businesses. At the same time, the Group aims to increase its earning power and build price by innovation and development. The Bayer brand name stands for trust, reliability and top quality through the environment. In fiscal 2021, the Team used all over a hundred,000 folks and had profits of forty four.1 billion euros. R&D costs ahead of unique products amounted to 5.three billion euros. For far more information and facts, go to

Uncover far more info at

Comply with us on Facebook:

Comply with us on Twitter: @BayerPharma

Forward-Seeking Statements

This release may well comprise ahead-seeking statements centered on current assumptions and forecasts made by Bayer administration. Several known and unfamiliar dangers, uncertainties and other factors could guide to substance variations among the real upcoming results, financial situation, development or functionality of the organization and the estimates supplied right here. These components incorporate people talked over in Bayer’s community stories which are accessible on the Bayer website at The business assumes no liability in any way to update these ahead-hunting statements or to conform them to potential activities or developments.

Read More

You May Also Like